Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for clinical symptoms of inoperable malignant bowel obstruction
2009-012981-30Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lanreotide in malignant bowel obstruction (MBO) and bowel obstruction, sponsored by Ghent University Hospital. Started Jul 2009; status: completed.
02
Drugs
lanreotide
03
Conditions
malignant bowel obstruction (MBO)bowel obstruction
Beyond the preview
Go deeper on 2009-012981-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012981-30.